Skip to content

Study of Herbal Powder in Piles of Adults

"Randomized Controlled Trial of Grunjanak Churna in Arsha(Internal Haemorrhoids)"

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/04/042246
Enrollment
70
Registered
2022-04-28
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K928- Other specified diseases of the digestive system

Interventions

Intervention1: Grunjanak Churna: 3gm BD for 30 days Control Intervention1: Krushna Tila Kalka: 3gm BD for 30days

Sponsors

Rohini Kendre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Subjects with age group between 18-45yrs 2. Both male and female patients 3. Patients diagnosed as first and second degree Internal hemorrhoid with bleeding will be selected for the study 4. Patients complaining of constipation

Exclusion criteria

Exclusion criteria: Patients suffering from Arsha associated with following disease will be excluded 1. Patients found associated with prolapsed piles, non reducible, thrombosed piles will be excluded from the study 2. Hypertension, Human Immuno deficiency Virus positive patients 3. Patients having Hb 4. Patients suffering from any Systemic disease

Design outcomes

Primary

MeasureTime frame
To assess the effect of Grunjanak Churna in constipation And bleeding per rectum in cases with Arsha (Internal haemorrhoids)Timepoint: 4weeks

Secondary

MeasureTime frame
a. To study the efficacy of Grunjanak Churna on Arsha on the basis of bleeding per rectum. b. To study the effect of Krushna Tila Kalka on the basis of bleeding per rectum c. To compare the efficacy of Grunjanak Churna and Krushna Tila Kalka on the basis of bleeding per rectumTimepoint: 30days

Countries

India

Contacts

Public ContactRohini Maroti Kendre

Government Ayurveda College and Hospital, Nagpur

sumeetasjain@gmail.com9373111200

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026